Does CVS Caremark cover Wegovy injection and tablet for weight loss?

Covered. Wegovy has been the preferred GLP-1 for weight management on the template formularies since 2025, in both injection and tablet form.

Does CVS Caremark cover Zepbound for weight loss?

Covered. Returning to the commercial formularies as an additional preferred option on 1 October 2026, after being dropped in May 2025 in favor of Wegovy. Before that date, plans following the template formulary do not cover it.

Does CVS Caremark cover Foundayo for weight loss?

Covered, prior authorization. The new-to-market block on Foundayo was removed on 1 June 2026, "where approved for coverage by plans".

Pharmacy benefit manager

Does CVS Caremark cover GLP-1s for weight loss?

CVS Caremark is a pharmacy benefit manager, so it publishes template formularies that employers may adopt. It states that "plan sponsors that adopt CVS Caremark template formularies retain discretion to customize coverage for their members", and describes the Zepbound change as applying "for plan sponsors who elect to provide coverage".

By John Weeks Checked against the primary source August 25, 2026

Your employer decides, not CVS Caremark. On most commercial plans, whether weight-loss medication is covered at all is chosen by whoever buys the plan. The criteria below apply only once that choice has been made, so the first document to read is your own plan's benefit summary.

What CVS Caremark covers for weight loss, and the criteria that apply.
Medication	Position	What it asks for
Wegovy injection and tablet	Covered	Wegovy has been the preferred GLP-1 for weight management on the template formularies since 2025, in both injection and tablet form.
Zepbound	Covered	Returning to the commercial formularies as an additional preferred option on 1 October 2026, after being dropped in May 2025 in favor of Wegovy. Before that date, plans following the template formulary do not cover it. Changed October 1, 2026
Foundayo	Prior authorization	The new-to-market block on Foundayo was removed on 1 June 2026, "where approved for coverage by plans". Changed June 1, 2026

Wegovy injection and tablet Covered

Wegovy has been the preferred GLP-1 for weight management on the template formularies since 2025, in both injection and tablet form.
Zepbound Covered

Returning to the commercial formularies as an additional preferred option on 1 October 2026, after being dropped in May 2025 in favor of Wegovy. Before that date, plans following the template formulary do not cover it.

Changed October 1, 2026
Foundayo Prior authorization

The new-to-market block on Foundayo was removed on 1 June 2026, "where approved for coverage by plans".

Changed June 1, 2026

Worth knowing

Caremark is the benefit manager rather than the insurer, so the same formulary sits behind plans sold under several different insurer brands, including Aetna.

Asking about one medicine instead

If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

1 cited records

1
CVS Caremark delivers affordability and access to GLP-1 weight management medications with expanded coverage options
CVS Health Primary text read and checked Checked August 25, 2026